IIC1001-Thapsigargin
Thapsigargin,>98%
【英文同义名】:CHEMBL96926; CHEBI:9516; TG
【中文同义名】:毒胡萝卜素
订购信息:(原装进口,常备现货)
| 品 牌 | 产品名称 | 产品货号 | 规 格 | 目录价(元) |
| Gene Operation | Thapsigargin (SER Ca2+ ATPase inhibitor) | IIC1001-0001MG | 1 MG | 1129.00 |
| IIC1001-0005MG | 5 MG | 3989.00 |
产品描述
Thapsigargi (同义名:CHEMBL96926; CHEBI:9516; TG [PF 02341066] [PF02341066] [PF 1066] [PF1066] [PF 2341066] [PF2341066])是sarco/endoplasmic reticulum Ca2+ ATP酶的非竞争性,细胞通透的强效抑制剂。 Thapsigargi分离自植物 Thapsia garganica,是一种非TPA型皮肤癌致癌物,可诱导小鼠耳朵炎症反应及小鼠皮肤中HDC活性[1]。它Thapsigargin使内质网钙池排空,通过抑制肌质网/内质网Ca2+ ATP酶来抑制Ca2+ 流向内质网,从而提高胞质内Ca2+浓度[2]。 Thapsigargin诱导ATF3启动子/荧光素酶报告基因转录,并可以上调不同细胞中ATF3的表达,如人HaCaT角化细胞,神经胶质瘤细胞,肝瘤细胞,视网膜色素表皮细胞和呼吸道上皮细胞[3,4]。另外,thapsigargin还可以诱导成神经细胞瘤细胞(SH-SY5Y)及胎鼠大脑皮层细胞凋亡[5]。Thapsigargin能显著提高DN 14-3-3η转基因小鼠中GRP78和TRAF2的表达[6]。已有报道称thapsigargin会引起围产期啮齿类动物大脑组织损伤[7]。
靶点
化学特性
| Cas No.: 67526-95-8 | 分子量: 650.76 |
| 分子式: C34H50O12 | 纯度: >98% |
| 同义名: CHEMBL96926; CHEBI:9516; TG |
| 化学名: (3S,3aR,4S,6S,6aR,7S,8S,9bS)-6-(acetyloxy)-4-(butyryloxy)-3,3a-dihydrox y-3,6,9-trimethyl-8-{[(2Z)-2-methylbut-2-enoyl]oxy}-2-oxo-2,3,3a,4,5,6,6a,7,8,9b-decahydroazuleno[4,5-b]furan-7-yl octanoate |
外观: 无色或白色的固体 |
| 溶解: 溶于DMSO(up to 100 mg/ml) |
| 保存:3年 -20℃ 固体 |
储存液配制
| 储存液 (1 ml DMSO体系) | 1 mM | 5 mM | 10 mM | 25 mM | 50 mM | 100 mM |
| 质量(mg) | 0.6508 | 3.2538 | 6.5076 | 16.2590 | 32.5380 | 65.0760 |
结构式

使用浓度(仅作参考)
Thapsigargin的具体使用浓度请参考相关文献,并根据自身实验条件(如实验目的,细胞种类,培养特性等)进行摸索和优化。
参考文献
[1] Hakii H., et al. Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanolphorbol-
13- acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol. 111 (3): 177–81 (1986).
[2] Davidson GA, et al. Kinetics of thapsigargin-Ca(2+)-ATPase (sarcoplasmic reticulum) inter- action reveals a two-step binding mechanism and picomolar inhibition. J Biol Chem. 270(20): 11731-4 (1995).
[3] Thastrup O, et al. Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. Agents Actions. 27(1-2):17-23 (1989).
[4] Inesi G, et al. Thapsigargin, a high affinity and global inhibitor of intracellular Ca2+ transport ATPases. Arch Biochem Biophys. 98(2):313-7 (1992).
[5] Treiman M, et al. A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases. Trends Pharmacol Sci. 19(4):131-5 (1998).
[6] Jackisch C, et al. Delayed micromolar elevation in intracellular calcium precedes induction of apoptosis in thapsigargin-treated breast cancer cells. Clin Cancer Res. 6(7):2844-50 (2000).
[7] Ding WX, et al. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem. 282(7):4702-10 (2007).